CDB15:0000052 AMH — EGFR

Experimentally validated in Human; Orthology-inferred in Mouse, Rat, Frog, Zebrafish, Chicken, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep

Title

Journal:; Year Published:

Abstract

Reduction of epidermal growth factor receptor phosphorylation by activated Mullerian inhibiting substance is vanadate-sensitive.

Metabolism: clinical and experimental, 1996; PubMed, Homo sapiens AMH — Homo sapiens EGFR
ABSTRACT: The carboxy-terminal domain of recombinant human Mullerian inhibiting substance (MIS) inhibits cellular proliferation in vitro and decreases epidermal growth factor (EGF)-dependent phosphorylation of the EGF receptor. Proteolytically cleaved and undissociated MIS is more potent than carboxy-terminal MIS alone, supporting a functional role for the amino-terminal region of the molecule. MIS does not block EGF binding to the EGF receptor, thus, MIS reduction of EGF receptor phosphorylation must occur distal to receptor ligand binding. The effect of proteolytically cleaved MIS on reduction of EGF receptor phosphorylation in membrane preparations is decreased by a specific phosphatase inhibitor, vanadate, thus implicating a membrane phosphatase in this MIS action at the EGF receptor.
Basic Information on AMH
Ligand Name: anti-Mullerian hormone
Other Symbols: MIF, MIS
Ligand Location: secreted based on hpa, perplexity, uniprot
Interactions with other Receptors for AMH
Basic Information on EGFR
Receptor Name: epidermal growth factor receptor
Other Symbols: ERBB, ERBB1, ERRP
Receptor Location: cell membrane based on hpa, perplexity, uniprot
HGNC Gene Symbol Report: EGFR
GeneCards: EGFR
HGNC Gene Group: Receptor kinases